rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
9
|
pubmed:dateCreated |
2007-4-26
|
pubmed:abstractText |
The CRF antagonist pharmacophore is a heterocyclic ring bearing a critical hydrogen-bond acceptor nitrogen and an orthogonal aromatic ring. CRFR1 antagonists have shown a 40-fold and 200-fold loss in potency against the CRFR1 H199V and M276I mutant receptors, suggesting key interactions with these residues. We have derived a two component computational model that correlates CRFR1 binding affinity within the reported series to antagoinst/H199 complexation energy and M276 hydrophobic contacts.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0022-2623
|
pubmed:author |
pubmed-author:CombsAndrew PAP,
pubmed-author:DavisAmy LAL,
pubmed-author:DzierbaCarolyn DCD,
pubmed-author:EbeltoftSarah MSM,
pubmed-author:GilliganPaul JPJ,
pubmed-author:Kasireddy-PolamPadmajaP,
pubmed-author:KlaczkiewiczJohn DJD,
pubmed-author:MolskiThaddeus FTF,
pubmed-author:PechulisAnthony DAD,
pubmed-author:RafalskiMariaM,
pubmed-author:SweetMark PMP,
pubmed-author:TakvorianAmy GAG,
pubmed-author:TebbenAndrew JAJ,
pubmed-author:TrainorGeorge LGL,
pubmed-author:WildeRichard GRG,
pubmed-author:WooAlex MAM,
pubmed-author:YangZhicaiZ,
pubmed-author:ZaczekRobert CRC,
pubmed-author:ZhangGeG
|
pubmed:issnType |
Print
|
pubmed:day |
3
|
pubmed:volume |
50
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2269-72
|
pubmed:meshHeading |
pubmed-meshheading:17402721-Animals,
pubmed-meshheading:17402721-Choroid Plexus,
pubmed-meshheading:17402721-Frontal Lobe,
pubmed-meshheading:17402721-Models, Molecular,
pubmed-meshheading:17402721-Pteridines,
pubmed-meshheading:17402721-Pyridazines,
pubmed-meshheading:17402721-Quantitative Structure-Activity Relationship,
pubmed-meshheading:17402721-Radioligand Assay,
pubmed-meshheading:17402721-Rats,
pubmed-meshheading:17402721-Receptors, Corticotropin-Releasing Hormone,
pubmed-meshheading:17402721-Swine
|
pubmed:year |
2007
|
pubmed:articleTitle |
Dihydropyridopyrazinones and dihydropteridinones as corticotropin-releasing factor-1 receptor antagonists: structure-activity relationships and computational modeling.
|
pubmed:affiliation |
Discovery Chemistry, Neuroscience Biology, Bristol-Myers Squibb Pharmaceutical Research Institute, 5 Research Parkway, Wallingford, Connecticut 06492, USA.
|
pubmed:publicationType |
Journal Article,
In Vitro
|